Home -> Law Blog Directory -> Personal Injury Law Blogs -> Drug Injury Watch
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Drug Injury WatchPsoriasis Drug Raptiva Alleged To Have Caused Hodgkin's Lymphoma Just Before April 2009 Recall
By Tom Lamb
2011 Raptiva Lawsuit Filed In Texas Against Drug Company: Failure To Warn About Side Effect Risks
(Posted by Tom Lamb at DrugInjuryWatch.com)
Back in 2009, we told you about some of the developments which led to Raptiva being withdrawn from the market in these two articles:
-- A Timeline For The Psoriasis Drug Raptiva, From Product Launch In U.S. To Market Withdrawal (April 2009)
-- FDA Warns About Rare Brain Infection PML Linked To Psoriasis Drug Raptiva (February 2009)
Now, a couple of years later, we have a products liability lawsuit that has been filed in Texas alleging that Raptiva was what caused a psoriasis patient to be diannosed with Hodgkin's lymphoma in March 2009, just a month before the Raptiva recall in the U.S.
From a January 7, 2011 Bloomberg news report, "Roche Sued by Patient Claiming Cancer From Pulled Psoriasis Drug Raptiva", we get these details:
- Houston-area psoriasis patient Cary Massa, 51, was diagnosed with classic Hodgkin?s lymphoma in March 2009, after taking Raptiva from February 2006 to January 2008, according to a complaint filed today in Houston federal court.
- The case is Massa v. Genentech Inc. and Xoma (US) LLC, 4:11-cv-00070, U.S. District Court, Southern District of Texas (Houston).
- Genentech was acquired by Roche Holding in March 2009, the month before the company began pulling Raptiva from the market. The company estimated 2,000 U.S. patients were taking the drug at that time, generating U.S. sales of $108 million in 2008.
We expect that there will be more drug injury lawsuits filed against Roche and Genentech by patients who developed progressive multifocal leukoencephalopathy, or PML, a rare but fatal brain infection -- which was the primary reason Raptive was withdrawn from the market in April 2009 -- as well as other serious side effects such as Hodgkin's lymphoma and other cancers after using Raptiva.
______________________________________________________________________________
DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects
Drug Injury Case Evaluation - Free & Confidential
Full post as published by Drug Injury Watch on January 13, 2011 (boomark / email).
Bausch Lomb Renu Moistureloc Linked to Eye Infection Fusarium Keratiti
Contact Lens Solution Product Recall
Bausch Lomb Renu Moistureloc Recall
Contact Lens Solution Product Recall
Mitchell Report Summary
Report on Steroid Drug Use in Major League Baseball by Senator George Mitchell
Pet Food Recall and Deaths
Dogs and Cats Sickened by Tainted Menu Food Products
Mattel and Fisher-Price Toy Recall
Magnets and Lead Paint manufactured in China Create Poisoning and Health Hazard
Cardiac Arrhythmia Drug Recalled
Recall Affects 1 lot of 225 mg Propafenone Tablets
Lymphoma, Leukemia
Linked to TNF Blockers
Raptiva
3 Patients Dead from Therapy-Related PML
Drug Manufacturer Rebates
Caremark Corp. agrees to pay $38.5 million settlement after convincing doctors to switch drug brands.
FDA Issues Warning Regarding Topical Ibuprofen Drug Products
Topical Ibuprofen Drug Products FDA Issues Warning Letters
Digitek Recalled
the heart drug allegedly contains double the medication that it should

Raptiva-Genentech's Psoriasis Drug is Recalled
Raptiva Recall Attorneys: Deadly Side Effects Lead to Recall and Consumer Outrage
Raptiva Joins List of Drugs with Deadly Side Effects
Raptiva Brain Damage Lawyers: Raptiva Users Worry about Side Effects
Raptiva Risks Outweighed Benefits
Psoriasis Drug Raptiva Suspended in Other Countries. Not in US.







